Concord Biotech Ltd 2025 Annual Report with Sustainability Disclosures
Company: Concord Biotech Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 257
The report highlights strong FY25 financial performance, including revenue from operations of ₹1,200.1 crore and 18% year-over-year growth. It describes the commissioning of a new injectable facility and a 26% investment in Cleanmax Everglades to support renewable power at the Dholka plant. Scope 1 and Scope 2 emissions data were independently assessed by DQS. The report also states that the company did not seek independent assurance for the report beyond the annual financial statements.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.